The Psychedelics Industry: Psychedelic Evangelism in Second Wave Research
Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.

Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.

By Matthew Chun In recent months, generative artificial intelligence (AI) has taken the world by storm. AI systems like ChatGPT and Stable Diffusion have captured the imagination of the masses with their impressive and sometimes controversial ability to generate human-like text and artwork. However, it may come as a surprise to some that — in…

In a post-Roe America, life, liberty, and the pursuit of happiness are all in jeopardy, especially for individuals who struggle with substance use.

How should the FDA regulate recreational drugs, if it has the power to do so?

Microdosing is certainly possible under the Oregon Psilocybin Services Act.

One understudied condition for which small doses of psychedelic substances such as psilocybin may be beneficial is cluster headache.

Law and policy around microdosing of psychedelic substances should reflect its proportionally low risks.

One primary aim of our study was to describe microdosing practices and motivations and consider how these factors vary across subgroups.
